Goldman Myla Lai
CIK: 0001168581
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 8, 2026QTRX
Quanterix Corp
Exercise(M)Direct8.1K shares- - May 4, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)Direct791 shares- - Jan 2, 2026QTRX
Quanterix Corp
Award(A)Direct23.4K shares- - Jan 2, 2026QTRX
Quanterix Corp
Award(A)Direct1.9K shares- - Oct 1, 2025QTRX
Quanterix Corp
Award(A)Direct2.1K shares at avg. $5.54$12K - Jul 8, 2025QTRX
Quanterix Corp
Award(A)Direct24.5K shares- - Jul 8, 2025QTRX
Quanterix Corp
Award(A)Direct2.9K shares- - Jul 8, 2025AKYA
Akoya Biosciences, Inc.
Other(J)Direct20K shares- - May 6, 2025WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)Direct1.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 |  QTRX Quanterix Corp | Exercise(M) | 8,073 | - | $0 | Direct |
| May 4, 2026 |  WST WEST PHARMACEUTICAL SERVICES INC | Award(A) | 791 | - | $0 | Direct |
| Jan 2, 2026 | QTRX Quanterix Corp | Award(A) | 23,372 | - | $0 | Direct |
| Jan 2, 2026 | QTRX Quanterix Corp | Award(A) | 1,944 | - | $0 | Direct |
| Oct 1, 2025 | QTRX Quanterix Corp | Award(A) | 2,084 | $5.54 | $11,545 | Direct |
| Jul 8, 2025 | QTRX Quanterix Corp | Award(A) | 24,464 | - | - | Direct |
| Jul 8, 2025 | QTRX Quanterix Corp | Award(A) | 2,940 | - | - | Direct |
| Jul 8, 2025 |  AKYA Akoya Biosciences, Inc. | Other(J) | 20,000 | - | - | Direct |
| May 6, 2025 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) | 1,071 | - | - | Direct |
1-9 of 9 transactions
About LAI GOLDMAN MYLA
LAI GOLDMAN MYLA (SEC CIK 0001168581) files insider reports with the SEC as Director of Quanterix Corp (QTRX), Director of WEST PHARMACEUTICAL SERVICES INC (WST) and Director of Akoya Biosciences, Inc. (AKYA).
Signal8 holds 8 ownership filings by LAI GOLDMAN MYLA (1 Form 3, 7 Form 4), filed between May 8, 2025 and Jul 9, 2026. Those filings report 9 transactions, from May 6, 2025 to Jul 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LAI GOLDMAN MYLA's filings is in BILLERICA, MA.
Recent filings by LAI GOLDMAN MYLA
- Jul 8, 2026: Option exercise of QTRX shares (Form 4, code M).
- May 4, 2026: Grant or award of WST shares (Form 4, code A).
- Jan 2, 2026: Grants or awards of QTRX shares (2 lines, Form 4, code A).
- Oct 1, 2025: Grant or award of QTRX shares (Form 4, code A).
- Jul 8, 2025: Grants or awards of QTRX shares (2 lines, Form 4, code A).
Other insiders filing for Quanterix Corp (QTRX)
- Miller Michael Francis, Chief Technology Officer
- Magovcevic-Liebisch Ivana, Director
- Mendel Scott, Director
- DONNELLY WILLIAM P, Director
- Gute James Edward Jr., Chief Commercial Officer
- Elliott Jeffrey Thomas, Director